2024 SPEAKERS

Demonstrating an unwavering commitment to the field of infection prevention, Dr. Alexander, Director of Infection Prevention and Control and CEO of MICRO Consulting Corporation since 2019, has charted a professional trajectory highlighted by groundbreaking initiatives, notably at Mount Sinai...

Dr Alombah, Fozo is a physician with over 16 years’ experience providing technical assistance to international health programs, in addition to 13 years of hands-on clinical and public health practical experience gained in Cameroon, his home country. He currently serves as Principal Technical...

Currently, Global Therapeutic Area Head for Infectious Diseases at Menarini Group. His over 25 years’ experience and expertise in Pharma covers various disease fields including CNS, Gastroenterology, Bone diseases, oncology and infectious disease & vaccines at Pfizer, Procter & Gamble...

Dr Afreenish Amir (MBBS, M.Phil, PhD (Microbiology), MPH, CHPE, DHM, PhD Public Health) has over sixteen years of experience in clinical microbiology and infectious diseases. She is working on implementation of National Action Plan on One Health Antimicrobial Resistance, Laboratory systems, AMR and ...

Dr. Kayla Antosz attended pharmacy school at the South Carolina College of Pharmacy and graduated in 2019. She then pursued a PGY1 and PGY2 residency in Infectious Diseases at Prisma Health Richland in Columbia, SC. She currently is a clinical instructor at the University of South Carolina College...

I have over 16 years of experience as an infectious disease specialist with most of my career spent caring for a diverse population of patients in community and academic settings. I previously served as Infectious Disease Department Chair of a large health system and Director of one of the busiest...

Mark Bamforth is a General Partner in the Kineticos Anti-Microbial Resistance Accelerator (KAMRA) Fund I. Previously, he founded, grew and sold three PE-backed contract development and manufacturing organizations (CDMO); specifically, Arranta Bio, founded in 2019 to focus on the microbiome, which...

Akhil is a clinical doctor and global health researcher based in London. He  runs the AMR Funding Circle, a grant making coalition of philanthropic funders interested in AMR. He is also working with the University of Chicago Market Shaping Accelerator on developing a new advance market commitment...

Julia Barnes-Weise is the founder and Executive Director of the Global Healthcare Innovation Alliance Accelerator (GHIAA), a non-profit organization that develops, promotes and consults on the use of tools and best practices to achieve equitable access through global health alliance formation. In...

I am a strategist, scientific writer, and senior manager who translates public health science into application. The intersection of individual and collective human behavior with external influence is one of my many passions rooted in the belief that we can more effectively improve individual and...

Prior to joining StartEngine, Harrison worked on JP Morgan's Leveraged Finance team, originating and syndicating over $10B in debt financing for clients. Three years ago he came over to the equity crowdfunding space, helping build out StartEngine's Fundraising Team by working with founders...

A veterinarian by training, Catherine has worked for over fifteen years in public health communication, with a strong focus on "One Health.” She specialises in global health communication, risk communication, infodemic management, and the training of international health professionals. For...

Michael P. Bevilacqua, MD, PhD has 35+ years’ experience as a medical scientist, inventor, and executive. As co-founder, CEO, and CSO of Macro Biologics (formerly known as Amicrobe, Inc.), Dr. Bevilacqua has led the development of its intellectual property, technology platform, and lead...

Physician, scientist, innovator, entrepreneur and academic teacher at the Medical University of Warsaw. Founder and CEO of Human Biome Institute – being his research commercialization. Winner of the prestigious Award of the 5th Faculty of Medicine of the Polish Academy of Sciences. In 2020, he was ...

Geremi Boom is an Emergency Medicine clinical pharmacist currently serving as a Medical Science Liaison at bioMerieux. She attended Northern Arizona University where she received her undergraduate degree in chemistry and later attended the University of Colorado for her doctorate in pharmacy. She...

Amy B. Cadwallader, PhD is the Directory of Regulatory and Public Policy Development at the U.S. Pharmacopeia (USP) where leads development of USP regulatory and public policy positions and is responsible for the creation of evidence-based policy content to advance the supply of quality medicines...

Megan Coffee, MD, PhD  is the International Rescue Committee communicable disease advisor. She is a clinical assistant professor at NYU Grossman School of Medicine and an infectious disease attending physician at Bellevue Hospital in New York City. Her research focuses on machine learning...

Angela (Angie) Coulliette-Salmond, Ph.D., is an environmental public health microbiologist at the Centers for Disease Control and Prevention (CDC) in the Division of Healthcare Quality Promotion, Clinical and Environmental Microbiology Branch. She also is an Officer in the U.S. Public Health...

César de la Fuente is a Presidential Assistant Professor at the University of Pennsylvania, where he leads the Machine Biology Group. He completed postdoctoral research at the Massachusetts Institute of Technology (MIT) and earned a PhD from the University of British Columbia (UBC). His research...

Currently, Mr. DeLuccia is Executive Chairman of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP), a New York-based, late development-stage biopharmaceutical company which he co-founded in 2017 and is focused on developing a new class of antibiotics, DNA pol IIIC inhibitors, to treat common infections...

I taught English in Montgomery County Public Schools in Maryland for nine years before launching a career as a freelance journalist in 2001. I wrote for The Washington Post, Woman's Day, Costco Connection, and other local and national health, lifestyle, and travel publications. My work also...

Based in the US, Dr. Dunton, as the Director of Palatin Technologies, brings a wealth of experience with over three decades in senior pharmaceutical roles. Notably, he served as the President and Managing Director of the Janssen Research Foundation (J&J Research). Dr. Dunton successfully...

Rahul is responsible for developing and executing strategies to enable access for life-saving antibiotics in LMICs. Overall responsibility for GARDP's portfolio of antibiotics targeted at saving patients suffering from life threatening sepsis caused by CR bacterial infections.

Denise Eblen, PhD - Dr. Eblen serves as the Assistant Administrator for the Office of Public Health Science (OPHS) at the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS). In this position, Denise plays a key role in FSIS’ efforts to protect public health by preventing...

The Global AMR R&D Hub is a partnership of countries and intergovernmental organisations working to address challenges and improve coordination and collaboration in  AMR R&D. Suzanne works to shape their approach to incentives. Previously, she was a freelance researcher and analyst...

Maud is Managing Director and co-founder for the Lixa group of companies, developing resistance breakers and antibiofilm agents with a mission to solve AMR for anyone, anything, anywhere. As mother of an AMR survivor, she is passionate about the patient voice and developing fit-for-purpose...

Aleks Engel is a partner with Novo Holdings where he has worked for 10 years.  He is the Director of the REPAIR Impact Fund, a founding board member of the AMR Action Fund, and a board member of Paratek Pharmaceuticals, a commercial anti-infectives company.  Aleks is based in Boston

Heather Entenmann has worked in the vaccine industry for nearly 20 years where she combines her public health expertise and passion with business strategy.  Two years ago, Heather joined the Sanofi US Public Affairs & Patient Advocacy team leading initiatives focused on vaccine...

Dr. Cara Fiore is a Senior Regulatory Reviewer and Microbiologist at the Food and Drug Administration/Center for Biologics Evaluation and Research/Office of Vaccines Research and Review (FDA/CBER/OVRR) since 2007. Vaccines and related products intended for human use that are used for infectious...

Dr. Heather Fowler completed her Veterinary Medical degree at the University Of Pennsylvania School Of Veterinary Medicine in 2010. After veterinary school, she received a Master of Public Health in Applied Biostatistics and Epidemiology at the Yale School of Public Health. In 2011, Dr. Fowler...

Greg Frank is Director, Global Public Policy with Merck & Co, where he leads global antimicrobial resistance and pandemic preparedness policy. Previously Dr. Frank served as Senior Director, Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), where he led several...

Mr Graham is the Chief Executive Officer of Recce Pharmaceuticals. He was formerly Executive Director and has extensive experience in marketing, business development and commercialization of early-stage technologies with global potential. Mr Graham serves on Recce’s Board of Directors and has...

Dr. Harnett has been a "boots on the ground" clinician for over 20 years, spending 10 years as an emergency physician before establishing himself as a nationally respected physician and key opinion leader in urgent care medicine. In addition, he has been an active author and researcher -...

Tom has been part of Sepsis Alliance since 2007, serving as President and CEO since 2013. He has led Sepsis Alliance, the nation’s first and leading sepsis patient advocacy organization, to consecutive years of growth. Under Tom’s leadership, Sepsis Alliance’s main website Sepsis.org has grown to...

Teri holds a bachelor’s degree in nursing, is board certified in infection prevention and control, and has earned the designation of Fellow in the Association for Professionals in Infection Control and Epidemiology (FAPIC). She has been in nursing for 43 years. Her experience includes 27 years as a ...

Lauren Hunt is an infectious diseases pharmacist who has dedicated her career to antimicrobial and diagnostic stewardship. She serves as a Medical Science Liaison on bioMérieux’s US Medical Affairs Team. Her primary role focuses on continuously improving the value of diagnostics through medical...

Meet Marcel Ishimwe is a Founder and Executive Director of AMR Initiative Rwanda, a youth-led organization dedicated to combating Antimicrobial Resistance in Rwanda. Marcel Is an IREX Research Champion, One Health Activist with Leadership skills from Aspire Institute founded at Harvard University...

Amanda Jezek is the Senior Vice President for Public Policy and Government Relations at the Infectious Diseases Society of America (IDSA), which represents over 12,000 ID physicians and scientists.  Amanda oversees IDSA’s public policy and government relations department, with responsibility for...

Elijah Kahn-Woods is an Innovation Advisor at USAID's Center for Innovation and Impact (CII). Elijah has over a decade of experience working in global health, mostly working on innovation and market access projects in the infectious disease space. Elijah worked for several years on Clinton...

Riko Kimoto joined ASEF, an inter-governmental not-for-profit organization located in Singapore, in April 2016. She currently leads ASEF's thematic area of Public Health, known as ASEF Public Health Network (ASEF PHN). Prior to joining ASEF, she gained extensive experience working with NGOs in...

Dr. Chaitanya Koduri serves as the Director of International Government and Regulatory Engagement in the Global External Affairs division of the United States Pharmacopeia. In this capacity, Dr. Koduri oversees international regulatory partnerships involving the United States Pharmacopeia, global...

Dr. Kosaraju is the CEO and President of Phare Bio, a social venture using AI and deep learning to develop novel classes of antibiotics in partnership with Jim Collins’ lab at MIT. Phare is a recipient of TED’s Audacious Project to develop big and potentially powerful solutions to the world’s most...

Elaine Larson is Professor Emerita, School of Nursing and Mailman School of Public Health, Department of Epidemiology, Columbia University, and Senior Scholar in Residence, New York Academy of Medicine.  She is former Dean, Georgetown University School of Nursing and a Fellow in the National...

Maria has worked in Responsible Investment for almost 20 years, specialising in environmental, social and governance (ESG) research. She joined Legal & General Investment Management Ltd (LGIM) in January 2019 where she is a Senior Global ESG Manager leading the Stewardship team’s efforts on...

Matthieu Lewis, PhDSenior Market Strategy Manager, Takara Bio Europe Dr. Matthieu Lewis is a Senior Market Strategy Manager at Takara Bio Europe, where he specializes in advancing market strategies for genetic and molecular biology technologies, including PCR/qPCR products and automation...

Chris has a passion for optimising antimicrobial use and blends extensive academic, healthcare, government, industry and international AMS and AMR experience. He has been a UK registered pharmacist for over 30 years, with over 10 years as a specialist antimicrobial/Infectious diseases pharmacist in ...

Thomas Lodise, Pharm.D., Ph.D., is a Professor at Albany College of Pharmacy and Health Sciences, Albany, New York. He is also an infectious diseases clinical pharmacy specialist at the Stratton VA Medical Center, Albany, New York. His research encompasses three interrelated domains:...

James Love is Director of Knowledge Ecology International. His training is in economics and finance, and work focuses on the production, management and access to knowledge resources, as well as aspects of competition policy. The current focus is on the financing of research and...

Shailesh Maingi is the Managing Partner of Kineticos Life Sciences which he founded in 2007. Shailesh serves on the Investment Committees of all funds and leads the strategic direction of funds and the Management Company. Shailesh is active in sourcing new investment opportunities and overseeing...

  Susan Manganello began her career in clinical practice and has accumulated over 11 years of experience in the industry. She currently serves as a Lead in Public Affairs and Patient Advocacy at Sanofi. Her work focuses on the impact of flu on chronic medical conditions, educating both providers...

Vicky Maskell is a Communications and Engagement Strategist at Wellcome, with over 15 years experience using communications and engagement as a strategic lever for organisational success. This includes supporting Wellcome to effectively communicate about its work, to ensure it is bringing in the...

Dr Clive Mason joined LifeArc in August 2023 to take on the role of Programme Director, AMR in the Global Health Team. Clive is also the LifeArc lead within the recently announced AMR-focused initiative called ‘PACE’ (Pathways to Antimicrobial Clinical Efficacy, https://paceamr.org.uk/ ). PACE was...

Team Lead of Global Initiatives and Instruments, Department of Global Coordination and Partnership of AMR, AMR division, World Health Organization (WHO), Geneva, Switzerland. He is a Chemistry Biologist from the University of San Carlos of Guatemala, Master's Degree in Public Health by Rafael...

Anthony is a policy fellow in the Center for Global Development’s global health policy team. He leads CGD’s work on antimicrobial resistance (AMR), including modelling the macro-economic burden of AMR and was previously the technical lead of CGD’s working group, A New Grand Bargain to Improve the...

Medley, Alexandra (CDC/NCEZID/DFWED/OD) - Dr. Alexandra Medley is a veterinary epidemiologist and the current Associate Director for antimicrobial resistance with the Centers for Disease Control and Prevention’s Division of Foodborne Waterborne and Environmental Diseases. Prior to working at...

Justine Michel is microbiology advisor at Medecins Sans Frontieres, currently based in New York. She completed technical biological analysis university degree in France. Justine first worked in the marine biology research field before to work as microbiology laboratory technician in Necker children ...

Zoe Molyneux is a Policy Lead at the Wellcome Trust, focused on the delivery of policy, research and advocacy activities to support Wellcome’s infectious disease strategic programme. This includes work to support global-level action on antimicrobial resistance and reforming the R&D ecosystem...

Alex Moreland is co-founder and CEO of Xiretsa, a spinout from UC Santa Barbara which is developing selective membrane-remodeling antibiotics for critical AMR threats. Alex received his B.S. (UCSB, biology & chemistry) in 2012 and his Ph.D. (UCSB, chemistry) in 2019 under the guidance of...

Valerie Morley is a Senior Scientist in Pathogen Genetics at Ginkgo Biosecurity. She is responsible for research and development related to metagenomic infectious disease surveillance. Dr. Morley’s work includes developing antimicrobial resistance (AMR) surveillance strategies for wastewater in...

Molly Moss is a Global Health Policy Officer at the United Nations Foundation. Her work focuses at the intersection of public health and international affairs, with emphasis on multilateral processes that shape the policy landscape for health. Based in New York City, Molly facilitates engagement...

Carol Munro has a personal chair in Microbiology at the Institute of Medical Sciences, University of Aberdeen and is leader of the Microbiology & Immunity Research Theme (Microbiology and Immunity). She is co-founder and CSO of Brigid Biologics (Brigid Bio), designing and developing next...

Dr. Mushtaq is a board-certified physician in internal medicine and infectious diseases. As the lead Principal Investigator and Medical Director at Brooklyn Clinical Research, she conducts research in therapeutic areas of internal medicine, infectious diseases, HIV, and vaccines. Dr. Mushtaq and...

Jomana Musmar, MS, PhD, has over 15 years of federal experience and subject matter expertise within the interdisciplinary fields of biodefense, public health security, and health policy at grassroots, national, and international levels. She currently serves as the Executive Director of the...

Dr. Windi Muziasari has gained years of experience and the know-how to monitor antimicrobial resistance (AMR) from environmental samples such as wastewater, rivers, lakes, soils and manure during her PhD and PostDoc at the University of Helsinki, Finland. She wanted other researchers at...

Kevin Nguyen, PharmD, is a clinical specialist in infectious diseases at St Christopher's Hospital for Children in Philadelphia, PA. He also holds academic appointments as an adjunct professor for various physician assistant programs at Drexel University, Delaware Valley University, and Salus...

Stephen Obaro MBBS, FWACP, MRCP(UK), FRCPCH, FAAP, PhD is Professor of Pediatrics and Infectious Diseases, Helen and Robert Whitley Endowed Chair of Pediatric Infectious Diseases, Associate Director, Mary Heersink Institute of Global Health, University of Alabama at Birmingham, AL. USA.  He is a...

Latifat is the Principal for Health Policy and Insights for the Americas at Economist Impact. Working with a diverse team, she directs and executes top-tier, data-driven research and health policy analysis projects that encompass the public and private sectors of the global health...

Dr. Olans is a nationally recognized leader on nurses’ contributions to antimicrobial stewardship.  She has numerous publications in the nursing and medical literature, is a contributor to the National Quality Partners (NQP) Playbook for Antimicrobial Stewardship in Acute Care, and the NQP...

Innovate UK has a One Health approach to AMR, funding SMEs and industry to develop new vaccines, antimicrobials and therapies for infectious disease in both man and animals.  In addition, solutions.  In addition, capabilities and technologies are supported in Infection, Prevention and Control to...

Julie Paoline, MA, CPHA, CIC, FAPIC is a Public Health Specialist Supervisor in the Bureau of Epidemiology at the Pennsylvania Department of Health, for the Division of Healthcare Associated Infection Prevention. Her work includes coordinating outbreak investigation and response for high-concern...

Dr. Park has over 22 years’ experience working on improving international and domestic public health, including the areas of antimicrobial resistance, infection prevention and control, pandemic preparedness, epidemiology, and financing. He was most recently a Senior Specialist at the Global Fund in ...

Krupa Parmar, MSResearch Technologist/ FellowInfectious Diseases Research LaboratoryMayo Clinic, Rocheste MN Krupa Parmar is a Phage Researcher at Mayo Clinic's Infectious DiseasesResearch Laboratory in Rochester, MN. She is a qualified microbiologist and hasexperience in bacteriophage...

Dr. Pogorzelska-Maziarz is an Epidemiologist and Health Services Researcher. She is a Professor at the M. Louise Fitzpatrick College of Nursing at Villanova University. Her research focuses on prevention of healthcare-associated infections across the healthcare continuum and antibiotic...

Dr. Prendergast, based in the US, is a renowned executive in the pharmaceutical industry. Currently serving as the Chairman and Co-founder of Palatin Technologies, Inc. (NYSE: PTN) and the Lead Director of Nighthawk Biosciences (NYSE: HHWK), he brings over three decades of expertise in the...

Kavi Ramjeet, Head of Business Intelligence, FIND Kavi joined FIND in 2019 to serve as the Technology Scouting Lead and now leads the Business Intelligence Unit since 2021. Kavi supports FIND’s activities related to technology scouting,  landscaping, market research, industry partner selection and ...

Rachel is the Director of the BARDA Alliance for Johnson & Johnson Innovation, based at Johnson & Johnson Innovation – JLABS (JLABS) in Washington, DC. As BARDA Alliance Director, she is responsible for managing BLUE KNIGHT™, a joint initiative between JLABS and the Biomedical Advanced...

Dr. John Redd is an internist and medical epidemiologist who serves as Chief Medical Officer of the Medical Countermeasures Coalition.  John began his federal career as a clinical internist with the US Indian Health Service (IHS) in Shiprock, New Mexico. Following two years of training with CDC’s...

Carolyn Reynolds is a Co-founder of Pandemic Action Network (PAN), a global coalition of more than 400 organizations working to prevent the next pandemic, and a Senior Associate (non-resident fellow) for Global Health Policy at the Center for Strategic and International Studies. She currently...

Dr. David Ripin leads efforts at CHAI to improve access to medicines and diagnostics for diseases like HIV, malaria, and tuberculosis, through sustainable market interventions. Under his leadership, CHAI has implemented agreements with pharmaceutical companies reducing prices of key drugs and...

Ruben Rizzi, physician by training, SVP of Global Regulatory Affairs at BioNTech. I joined the company in December 2019 just before the pandemic, and I have been the global regulatory lead for BioNTech for our COVID-19 development. Currently, I am still supporting the lifecycle of our COVID-19...

Nikki Romanik is the currently the Special Assistant to the President, Deputy Director and Chief of Staff for the Office of Pandemic Preparedness and Response Policy (OPPR) in the Executive Office of the President at the White House. Prior to this role, Nikki was the Senior Policy Advisor for the...

Dr. Ronholm obtained her BSc in Microbiology from the University of Waterloo in 2007 and her Doctoral degree in microbiology and immunology from the University of Ottawa in 2013. She completed post-doctoral training at McGill University and at Health Canada. She was hired as an Assistant Professor...

JORGE SAAVEDRA MD, MPH, MSc. Executive Director of the AHF Global Public Health Institute. https://ahfinstitute.org/  Elected by the Mexican Senate as Member of the Consultative Council of the National Human Rights Commission of Mexico. Member of the Panel for a Global Public Health Convention...

Steven J. Schweon RN, MPH, MSN, CIC, LTC-CIP, CPHQ, FSHEA, FAPIC is a seasoned, board-certifiedinfection preventionist. He first became interested with infectious diseases while serving as a United States Army medic in South Korea, where he supervised a microbiology department that specialized in...

Peter is an infection immunologist by training with a PhD from ETH Zürich. With over 25 years of experience in research and development of vaccines and small molecules against bacterial and mycobacterial pathogens, he has worked with large pharma and small to mid-sized biotech in Switzerland and...

Taylor founded the Medical Countermeasures Coalition after serving as a Senior Advisor to the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. He advised the ASPR on many critical issues including the development and execution of...

Dr. Cecilia Mundaca Shah is the Senior Director for Global Health at the UN Foundation. In this role, Cecilia serves as the Foundation’s primary policy and technical lead on global health security, including pandemic prevention, preparedness, response, and antimicrobial resistance. She is...

Dr. Lindsey Shields the Deputy Director of PATH’s Epidemic Preparedness and Response Program.  She is a board-certified preventive medicine veterinarian with more than 13 years’ experience in strengthening infectious disease surveillance systems, supporting outbreak response, and implementing the...

Troy Skwor, Ph.D., is an Associate Professor of Biomedical Sciences and the Director of the Antibiotic Resistance and Antimicrobial Photodynamic Therapy Laboratory at the University of Wisconsin – Milwaukee. His laboratory focuses on identifying the clinical relevance of antimicrobial resistance in ...

Sarah Smathers, MPH, CIC, FAPIC is the System Director of Infection Prevention and Control (IPC) for the Children’s Hospital of Philadelphia (CHOP). Sarah serves on the Association for Professionals in Infection Control and Epidemiology (APIC) Board of Directors. She has recently served as Chair of ...

Richard Snyder, Ph.D. is a Venture Partner at the Kineticos AMR Accelerator Fund I. He is also the VicePresident for Science and Technology, Pharma Services at ThermoFisher Scientific where he scientificallyleads the S&T Team’s initiative developing multi‐generational manufacturing and...

Luka works as Associate Director in Health Security at IFPMA, where he manages the organization’s policy and advocacy work on AMR, including leading on the cross-functional area of Vaccines for AMR. In his role, Luka engages across industry and the global health community to identify solutions...

Britton received his Ph.D. in Microbe-Host Interactions from Vanderbilt University, where he studied the mechanisms of probiotic-mediated protection against respiratory viral infections. With experience in traditional microbiology, next-generation sequencing, and bioinformatics, he now aids...

Edie Stringfellow brings two decades of experience in public policy, global health equity, ecosystem development, and clinical research to her role as SVP Global Health Strategy & Biomedical Commercialization at Precia Group. She is committed to establishing Precia Group as a front-runner in...

Bala is a microbiologist and a drug hunter who received his PhD from the University of Wisconsin-Madison and post-doctoral training at the Albert Einstein College of Medicine, NY. Subsequently he gained leadership and management experience over two decades in the pharmaceutical industry. Among...

Amy Sylvis is a beacon of resilience, advocacy, and entrepreneurial spirit. As a 42-year-old woman living with cystic fibrosis and antimicrobial resistance, Amy embodies the spirit of overcoming obstacles.Her life story is one of overcoming significant health challenges to achieve remarkable...

Julia E. Szymczak, PhD is an Associate Professor in the Division of Epidemiology at the University of Utah School of Medicine, where she Co-Directs the Utah Quality Advancement Laboratory (UQuAL). Dr. Szymczak is a medical sociologist who leads research that integrates social science theory and...

Emily is a Manager in the Health Policy and Insights team at Economist Impact, based in New York City. In this role she works with global clients, managing the conceptualization, delivery, and execution of evidence-based health policy projects. Her responsibilities involve engaging with diverse...

Thomas Tillett – Cofounder and CEO of MBF Therapeutics, an immunotherapeutics company that has developed and patented an innovative, proprietary T-Max Precision™ DNA vaccine platform to deliver commercial protective vaccines that provide safe, durable, heterologous protection against...

Thomas C. Tsai, MD, MPH serves as Chief Medical Advisor for Gingko Biosecurity. In this role he provides strategic leadership on improving hospital-level wastewater surveillance and digital epidemiology tools. He is Co-Director of the Healthcare Quality and Outcomes Lab at HSPH where he leads...

Martijn van Gerven is a Research Lead of the AMR Programme at the Access to Medicine Foundation. At the Access to Medicine Foundation, we work every day to change how essential healthcare companies bring their medicines to people in low- and middle-income countries. The AMR programme includes the...

Dr. Jessica Vernon founded Maisha Meds while a medical student at Stanford. She was on the founding team of IPA/Evidence Action’s Dispensers for Safe Water program—which raised $10M, supported over a million people in East Africa, and was awarded a GiveWell top charity distinction in 2022. She was...

Nikunj Vyas is a Clinical Pharmacy Specialist/Infectious Diseases and Antimicrobial Stewardship at Jefferson Health – East Region. He received his PharmD from St. John’s University. He completed a PGY-1 Pharmacy Residency at Atlantic Health System in Morristown, NJ and then went on to complete a...

Emily Wheeler is Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO). Ms. Wheeler is responsible for working with member companies engaged in antimicrobial research, development, and commercialization, and leads BIO’s antimicrobial resistance (AMR) legislative...

Dr. C. Jo White has 37 years of clinical development, medical affairs, busines development, regulatory affairs and pharmacovigilance wxperience in the pharmaceutical industry.  Her experience has focused on antimicrobial and vaccine development.  Over the past 37 years, she has co-authored over 30 ...

J. Kenneth Wickiser worked for the US government in education and research for over 20 years before joining the Global Alliance for Preventing Pandemics (GAPP) team, a center at Columbia University dedicated to public health technical workforce development and retention, democratization of...

Adam Williams is currently Director, mRNA Commercial Strategy & Innovation at Pfizer, leading strategic efforts in global pandemic security, planning for a broad array of defenses, and driving Pfizer’s thought leadership in preparedness. Adam previously led strategy and market intelligence at...

Mark Williams is an associate director at FasterCures, a center of the Milken Institute. He manages a number of projects aimed at creating a high-functioning biomedical system, including countering antimicrobial resistance, engaging patients within health systems, and fostering innovation and...

Boyd Wilson is the Care Group Director of Infection Prevention and Control for HealthPartners, based in Minnesota. HealthPartners, an integrated health care organization providing health care services and health plan financing and administration, is the largest consumer governed nonprofit health...

Doug Witt is the CEO and cofounder of Unison Medicines, a discovery-stage pharmaceutical company focused on solving the Anti-Microbial Resistance crisis.  Unison discovers novel small molecules which block bacterial DNA damage repair and associated stress responses.  Previously Doug worked at...

As compared to the gold standard nasopharyngeal swab, Wyllie’s work has identified saliva as a reliable sample type for the sensitive detection of Streptococcus pneumoniae (pneumococcus) in healthy individuals and more recently, during the COVID-19 pandemic response, for the detection of...

Jennifer Young is Vice President and Head, Global Business Policy and Public Affairs at Pfizer. Jennifer leads a diverse global team overseeing development and execution of public policy and government affairs strategies to shape the operating environment for Primary Care, Specialty Care, and...

  Kelly Zabriskie, MLS, BS, CIC, FAPIC, serves as the Enterprise Vice President of Infection Prevention (IP) for Jefferson Health in Philadelphia, overseeing 18 hospitals, 5 urgent care centers, and numerous outpatient practices. Ms. Zabriskie has been with Jefferson Health since 2016, initially...

John Zurlo, MD is The W. Paul and Ida Havens Professor and Director of the Division of Infectious Diseases at Thomas Jefferson University. He attended Regis High School in New York City, received his BS in Biology and Latin at Manhattan College, and received his MD degree from Albany Medical...